UNSPSC 51273608: Cocaine methiodide

This classification denotes a cns stimulant with the molecular formula C18H24NO4.I, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 83FKO5XD6J, chemically known as (-)-cocaine methiodide, but more generally known as cocaine methiodide, which bears US NIH Compound Identifier 83828. European Medicines Agency schedules cocaine methiodide or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13416MIG. Most nations, for tariff purposes, schedule cocaine methiodide under HS 29399110.

SMILES: C[N+]1([C@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)C3CCCCC3)C(=O)OC)C.[I-].

UNSPSC 51273608 Cocaine methiodide, a Commodity code, shows little relevant recent activity aligned with its nominal scope. The three most-recent state and local opportunities posted under this code—Seminole County's procurement of naloxone and drug deactivation systems, Texas HHS's RFI on direct-to-manufacturer prescription programs, and Minnesota MMCAP's RFP for generic multi-source pharmaceuticals and OTC products—address pharmaceutical procurement broadly but do not target cocaine methiodide or controlled pharmaceutical precursors as a line item. The code appears to be a misclassification artifact in state and local procurement systems; issuing bodies are actually buying naloxone (an opioid antagonist), generic pharmaceuticals through cooperative purchasing, and exploring direct pharmacy benefit management arrangements, none of which align with the code's stated commodity.

Activity is spread across multiple jurisdictions and issuing structures: Seminole County, Florida (a county health agency using competitive IFB); Texas Health and Human Services Commission (a state health department using RFI); and Minnesota MMCAP (a multistate cooperative purchasing vehicle administered by the Minnesota Department of Administration). The geographic spread includes Florida, Texas, and Minnesota, with MMCAP's reach extending to Oregon as well. None of the recent opportunities name cocaine methiodide as a procurement target, and the mismatch between the code's nominal scope and actual solicited work suggests the code does not reflect active state and local demand in pharmaceutical procurement right now. Business development professionals should verify whether this code accurately describes their service or product line; the recent activity does not support pursuing opportunities under this classification.